Correction: Bispecific antibody for lung cancer: mechanisms and clinical insights
Wei Chen, Afang Zhou, Yunfeng Zhou
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMonoclonal and Polyclonal Antibodies Research · RNA and protein synthesis mechanisms · Advanced biosensing and bioanalysis techniques
In the published article, there was an error. The first sentence of the Introduction section contained erroneous data for the annual new lung cancer cases. The original text incorrectly stated “22 million new cases,” which should be “2.2 million new cases” as cited in Reference 1.
A correction has been made to the section Introduction, Paragraph 1. This sentence previously stated:
“Lung cancer is one of the world’s most common cancers and the leading cause of cancer-related deaths, with an estimated 22 million new cases and 1.79 million deaths annually (1).”
The corrected sentence appears below:
“Lung cancer is one of the world’s most common cancers and the leading cause of cancer-related deaths, with an estimated 2.2 million new cases and 1.79 million deaths annually (1).”
The original version of this article has been updated.